Stock MDNA MEDICENNA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Medicenna Therapeutics Corp.

Equities

MDNA

CA58490H1073

Delayed Toronto S.E.
Other stock markets
 12:37:18 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.39 CAD -0.83% Intraday chart for Medicenna Therapeutics Corp. +3.02% +469.05%
Jun. 03 Medicenna Reports "Significant" Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp MT
Jun. 03 Medicenna Brief: Reporting "Significant" Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a "Matched External Control Arm" MT

Evolution of the average Target Price on Medicenna Therapeutics Corp.

Price target over the last 5 years

History of analyst recommendation changes

8c1755188ae1a8b.DrIXJ5QxKTTSeYlkWu7dLOk-8zhpVk-SWBMXUrwLypM.N-NuduJ-H3HgCv4JDdqbXKgOmgghbnfcLEtzN8p_jdZtgWQS43xCcLoh0A~cb243bb132f2844c9b9fe80f5c2844ea

Analyst Recommendations on Medicenna Therapeutics Corp.

Oppenheimer Adjusts Medicenna Therapeutics Price Target to $3 From $8, Maintains Outperform Rating MT
HC Wainwright Reiterates Medicenna Therapeutics at Buy With $2.50 Price Target MT
HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $2.50 From $4, Maintains Buy Rating MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $4 From $5, Keeps Buy Rating MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $8 From $10, Maintains Outperform Rating MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $5 from $7, Keeps Buy Rating MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $10 From $12, Maintains Outperform Rating MT
MEDICENNA THERAPEUTICS : HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $7 From $8, Maintains Buy Rating MT
MEDICENNA THERAPEUTICS : Oppenheimer Starts Medicenna Therapeutics at Outperform With $12 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.41 CAD
Average target price
6.15 CAD
Spread / Average Target
+155.19%
High Price Target
9 CAD
Spread / Highest target
+273.44%
Low Price Target
4.45 CAD
Spread / Lowest Target
+84.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medicenna Therapeutics Corp.

Oppenheimer
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MDNA Stock
  4. Consensus Medicenna Therapeutics Corp.